glp-1 and breastfeeding Breastfeeding: Safety Evidence and Clinical Consider... – PlexusDx GLP-1 Medications and Breastfeeding

The regulatory gap MEDVis business model depends on a narrowing regulatory gap

Ultimately, this pattern of compulsive seeking and consumptiondriven by neurobiological mechanismssignificantly contributes to the perpetuation of obesity [25], posing a challenge for interventions that do not effectively modulate the glycemic and insulinemic responses underlying these mechanisms

Conservative management strategies include: Optimize gastrointestinal function: Address constipation proactively with adequate hydration (individualized to the patient's cardiovascular and renal status), dietary fiber supplementation, and when necessary, osmotic laxatives such as polyethylene glycol

GLP-1s improve survivorship in people with DCIS People with ductal carcinoma in situ (DCIS) are at higher risk of the cancer coming back if they also have obesity and/or diabetes